Supplemental material and method from DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)